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Abstract
Background: Microbial deprivation early in life can potentially influence immune mediated disease development such as
allergy. The aims of this study were to investigate the influence of parental allergy on the infant gut colonization and
associations between infant gut microbiota and allergic disease at five years of age.
Methods and Findings: Fecal samples were collected from 58 infants, with allergic or non-allergic parents respectively, at
one and two weeks as well as at one, two and twelve months of life. DNA was extracted from the fecal samples and Real
time PCR, using species-specific primers, was used for detection of Bifidobacterium (B.) adolescentis, B. breve, B. bifidum,
Clostridium (C.) difficile, a group of Lactobacilli (Lactobacillus (L.) casei, L. paracasei and L. rhamnosus) as well as
Staphylococcus (S.) aureus. Infants with non-allergic parents were more frequently colonized by Lactobacilli compared to
infants with allergic parents (p=0.014). However, non-allergic five-year olds acquired Lactobacilli more frequently during
their first weeks of life, than their allergic counterparts, irrespectively of parental allergy (p=0.009, p=0.028). Further the
non-allergic children were colonized with Lactobacilli on more occasions during the first two months of life (p=0.038). Also,
significantly more non-allergic children were colonized with B. bifidum at one week of age than the children allergic at five
years (p=0.048).
Conclusion: In this study we show that heredity for allergy has an impact on the gut microbiota in infants but also that early
Lactobacilli (L. casei, L. paracasei, L. rhamnosus) colonization seems to decrease the risk for allergy at five years of age despite
allergic heredity.
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Introduction
During and after birth, the neonate is exposed to an array of
microbes, which immediately start to colonize the skin and
mucosal surfaces of the infant. The mode of delivery seems to play
an important role in early-life colonization. During vaginal
delivery, the neonate will be exposed to both vaginal and fecal
flora, while a child delivered by caesarean section predominantly
encounter skin bacteria [1]. The neonatal colonization pattern is
further influenced by several post-natal environmental factors such
as, the level of affluence, the number of siblings, the use of
antibiotics and infant feeding [2–4]. As several bacterial species
and bacterial components possess potent immunostimulatory
capacities, these differential exposures may have implications for
immune maturation [5–9]. Animal studies show that the gut
microbiota composition is associated with immune development,
maturation and function [8,10] and also in humans associations
between the early-life gut microbiota and mucosal and systemic
immunity during the first year of life have been reported [11–13].
The rapid increase in allergic disease observed in the past
decades is hypothesized to depend on microbial deprivation early
in life [14,15] Indeed, differences in the early infant gut microbiota
in relation to development of allergic disease have been reported in
some prospective studies [4,16–18], but not in others [19]. For
example, a reduced diversity [20] and lower counts of lactobacilli
and bifidobacteria seem to characterize infants later developing
allergy [4,16]. On the contrary, early Staphylococcus (S.) aureus and
Clostridium (C.) difficile colonization have been associated with
development of allergy in some studies [16–18].
In most of these previous studies, a pronounced majority of the
children have allergic heredity. Whether this influences the gut
microbiota colonization, is not known, but recent studies indicate
that host genetics is important for gut colonization [21]. Thus we
studied whether parental allergy influenced infant gut colonization
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was associated with future allergy development. Bacterial species
investigated here: B. adolescentis, B. bifidum, B. breve, C. difficile,a
group of Lactobacilli (L. casei, L. paracasei and L. rhamnosus) and S.
aureus were included based on previously reported associations
with allergic phenotypes during childhood. All children included
in the study were born vaginally, exclusively breast fed during their
first three months of life and none received antibiotics. Frequencies
and relative quantities of above-mentioned bacteria were deter-
mined using real time PCR. The children were clinically followed
to five years and diagnosed as allergic at the age of five only if the
presence of allergen specific IgE and/or a positive skin prick test
confirmed the allergic symptoms.
Methods
Study population
A total of 58 five-year old children and their mothers were
selected for this study from a prospective birth-cohort (n=281)
previously described in detail elsewhere [22].
Parents were included only if self reported allergic status was
confirmed with skin prick test (SPT) negative or positive results. The
58 infants, all born term (mean weeks 40, range 38–43), with normal
birth weights (mean 3,7 kg, range 2,7–4,6), vaginally delivered and
exclusively breast fed $3 months,were included based on availability
of fecal samples at several occasions during infancy. Moreover, none
of the infants received antibiotics the firstthree months of life. In total,
35 infants with allergic parents (60%) and 23 infants with non-allergic
parents (40%) were included and demographic data of the individuals
is displayed in Table 1. The subjects included in this study did not
differ from the original cohort in respect to exposures, such as
smoking, pets nor siblings (data not shown).
The study was approved by the Human Ethics Committee at
Huddinge University Hospital, Stockholm (Dnr 75/97, 331/02),
and the parents provided informed verbal consent. Families
expecting a child were asked by the midwife at the maternity ward
if they were interested in participating in the study. If so, the
pediatrician (C.N.) in charge contacted them, gave further
information and invited them to a seminar on allergies. If still
interested, appointments were made for blood sampling of the
parents, when approval of their participation was documented. No
written documentation of the participants informed approval was
required, which was agreed to by the Human Ethics Committee.
Skin prick testing and determination of allergen specific
IgE in circulation
At age five, SPT were performed against food and inhalant
allergens according to the manufacturer’s instruction (ALK,
Copenhagen, Denmark). The SPT included food allergens: egg
white (Soluprick weight to volume ratio 1/1000), cod (Soluprick 1/
20), peanut (Soluprick 1/20) cow’s milk (3% fat, standard milk), and
soybean protein (SojaSemp; Semper AB, Stockholm,Sweden). SPTs
were also performed for inhalant allergens: cat, dog, Dermatophagoides
farinae, birch and timothy (Soluprick 10 Histamine Equivalent Prick
test). Histamine chloride (10 mg/mL) and the allergen diluent were
the positive and negative controls, respectively. The SPT was
considered positive if the wheal diameter was $3m ma f t e r1 5
minutes. All parents were skin prick tested against the same inhalant
allergens as the children but also against horse, rabbit, and mugwort.
Serological analysis of specific IgE, to the same allergens tested
with SPT, was performed using ImmunoCAP (Phadia AB,
Uppsala, Sweden). Samples with allergen-specific levels of
$0.35 kUA/L were considered positive.
Clinical evaluation and classification of IgE-mediated
allergic disease
Subjects were followed from birth to five years of age and were
clinically examined by the same pediatrician (C.N.). At five years
Table 1. Demographic data of the study population.
All
(n=58)
Allergic Parents
(n=35)
Non-Allergic Parents
(n=23) p-value
Maternal age
Median (range)
31 (23–40) 32 (23–38) 30 (23–40) 0,359
#
Maternal smoking
n( % )
1 (1,7) 0 (0) 1 (1,7) 0,407
£
Paternal
smoking n (%)
6 (10,3) 4 (6,9) 2 (3,4) 1,000
£
Birth period
April-September
n( % )
October-March
n( % )
39 (67,2)
19 (32,8)
24 (68,6)
11 (31,4)
15 (65,2)
8 (34,8)
1,000
£
Siblings
median (range)
0 (0–5) 0 (0–5) 1 (0–3) 0,327
#
Day care
"
Attendance yes n (%)
Start month
Median (range)
45 (78,9)
17 (12–25)
27 (79,4)
17 (12–25)
18 (78,3)
17,5 (12–20)
1,000
£
0,638
#
Furred pets at home n (%) 10 (5,8) 2 (5,7) 8 (34,8) 0,01
£
IgE-mediated allergic disease
1 at five n (%) 20 (34,5) 16 (45,7) 4 (17,4) 0,047
£
#Mann Whitney Rank Sum test.
£Fishers Exact test.
"Missing data for one individual.
1IgE-mediated disease according to the WAO nomenclature [23].
doi:10.1371/journal.pone.0023031.t001
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SPT was positive ($3 mm) and/or if specific IgE to at least 1 of
the selected allergens was $0.35 kUA/l together with allergic
symptoms at five years of age [23]. Children with negative SPT
together with negative allergen specific IgE and not having any
allergic symptoms at five years of age were classified as non-
allergic (n=19). In addition to the allergic and non-allergic
children, fifteen children were non-sensitized but had symptoms
such as eczema (n=11) or asthma (n=4) thus they were excluded
in the five year analyses of infant microbiota in relation to IgE-
mediated allergy at five together with children lost in the follow up
(n=4).
Detection of bacterial species in fecal samples
The methods used in the study are previously published in detail
[4]. Briefly, infant fecal samples were collected at 1 and 2 weeks
and at 1, 2 and 12 months of age. Maternal fecal samples were
collected in connection to the delivery. The samples were brought
to the hospital on ice and stored at 270uC until analysis. DNA
from the fecal samples was extracted using the Qiamp DNA Stool
Mini Kit
TM protocol increasing the bacterial DNA of the human
DNA (Qiagen, Hilden, Germany). Extracted nucleic acid
concentration was measured with Bio-Rad Smartspec (Bio-Rad
Laboratories, Hercules, CA, USA) at 260 nm using Bio Rad
trUView Disposable Cuvettes (Bio-Rad Laboratories).
Real time PCR was used for analyses of bacterial DNA, using
SYBR Green chemistry with primer pair sequences and
concentrations previously published. Primer pairs used targeted
C. difficile, B. adolescentis, B. bifidum, B. breve, a group of Lactobacilli
(L. casei, L. paracasei, L. rhamnosus) [4] and S. aureus [24]. L. casei, L.
paracasei, L. rhamnosus were detected with one primer pair and will
be referred to as ‘‘Lactobacilli’’ from now on.
Reference bacterial DNA, purchased from LGC Standards
(Bora ˚s, Sweden) and Biotechon Diagnostics (Potsdam, Germany)
was used as standards and positive controls.
SYBR Green real-time PCR was performed using 96-well
detection plates in ABI prism 7000 (Applied Biosystems, Stock-
holm, Sweden). The Absolute Quantification protocol in 7000
SYSTEM software version 1.2.3f2 (Applied Biosystems) was used
together with a standard curve ranging 5 ng to 50 fg. All samples
were analyzed in triplicates with each well containing 2xPower
SYBR Green Mastermix (Applied Biosystems), primer pairs
(MWG-Bioteck, Edersburg, Germany), sample (DNA) and water.
Triplicates with CT values above 35 were considered negative
avoiding detection of false positives. Calculation of amount specific
bacterial DNA was performed from the standard curve using The
Absolute Quantification protocol in 2000 SYSTEM software.
Relating the amount of specific bacterial DNA to the total amount
of nucleic acids in each sample gives percentage of specific
bacterial DNA/total nucleic acids and is referred to as relative
amounts in percentage and the limit of detection was 5610
26%.
Statistics
Statistical analyses were performed at the Division of Mathe-
matical Statistics, Stockholm University. Fisher’s exact test was
used to evaluate differences in frequencies between the groups of
infants with allergic parents versus non-allergic parents, and also
between children who developed allergy as compared to the ones
remaining non-allergic. To assess differences in the relative
amounts of the detectable bacteria the Mann-Whitney Rank
Sum test was applied. Additionally, to investigate differences in the
number of occasions with the bacteria the first two months, Mann
Whitney Rank Sum test was used.
To assess the microbiota with respect to both allergic heredity
and allergic disease at age five, Fisher’s exact test was used for the
frequencies together with Kruskal Wallis Rank Sum test
comparing the relative amounts between all groups. Where
significant differences between all groups were obtained, further
pair wise statistical analyses were performed as above using
Fisher’s exact test and Mann-Whitney Rank Sum test. Many
statistical tests were performed, and no correction for multiple
testing was done, potentially generating false significances.
Results
Infants with non-allergic parents are frequently colonized
by Lactobacilli
Infants born to non-allergic parents (n=23) were significantly
more often colonized by the Lactobacilli at one week than infants
born to allergic parents (n=35) (Fig. 1A). This pattern was similar
at the other investigated occasions during the first two months of
life, although not statistically significant (Fig. 1A). The number of
occasions, having Lactobacilli during the first two months, was
significantly higher among infants with non-allergic parents
(Fig. 1B). Furthermore, the relative amounts of the Lactobacilli
were significantly higher or tended to be higher in infants with
non-allergic parents at one and two weeks as well as at one and
two months of age (p=0.013, p=0.065, p=0.036 and p=0.058
respectively) (data not shown).
In addition, the relative amounts of B. bifidum were significantly
higher in infants with non-allergic parents at one week of age
(p=0.044) (data not shown), but neither the frequencies (Table 2)
nor the amounts (data not shown) of the other species investigated,
differed with parental allergic status.
C. difficile was only detected in two infants during the first two
months of life whereas half of all children were colonized at twelve
months of age (Table 2). The opposite pattern was observed
regarding S. aureus, with many infants colonized early but few at
twelve months of age (Table 2).
At twelve months of age the infants with allergic parents seemed
more frequently colonized by all the species investigated,
compared to the children with non-allergic parents, although not
statistically significant (Fig. 1A, Table 2).
The early-life microbiota associates with IgE-mediated
allergic disease at five years of age
At the age of five, 20 children were considered allergic (SPT
$3 mm and/or allergen-specific IgE $0,35 kU/l together with
allergic symptoms) while 19 children fulfilled the criteria of being
non-allergic, as they showed no allergic symptoms and were non-
sensitized.
Frequencies of the different investigated species in relation to
allergy are depicted in Figure 2. The Lactobacilli tended to be
more commonly detected in early fecal samples from children who
were non-allergic at five years of age than in children who had
developed allergy (Fig. 2A). Moreover, the non-allergic children
were colonized with Lactobacilli on more occasions during the first
two months of life (p=0.038, data not shown) than the allergic
group. However, the relative amounts did not differ between the
groups (data not shown).
Additionally, the pattern of colonization was similar for B.
bifidum and B. breve (Fig. 2B–C). Non-allergic children were
significantly more colonized with B. bifidum at one week of age,
with a similar tendency at two weeks of age (Fig. 2B). The
colonization with B. breve or B. adolescentis did not differ with respect
to frequencies (Fig. 2C–D) or relative amounts (data not shown) at
any time point between the two groups. S.aureus frequencies, early
Early-Life Microbiota and Allergy
PLoS ONE | www.plosone.org 3 August 2011 | Volume 6 | Issue 8 | e23031Figure 1. Intestinal colonization with Lactobacilli in infants with allergic and non-allergic parents respectively. The y-axis shows
percentage infants colonized at the different time points (A) and percentage infants colonized 0, 1, 2, 3 or 4 occasions the first two months of life in
(B).
doi:10.1371/journal.pone.0023031.g001
Table 2. Frequencies of bacterial species in infants with allergic and non-allergic parents, respectively.
Occasion 1 week 2 weeks 1 month 2 months 12 months
All
n=57
A
parents
n=35
NA
parents
n=22
All
n=57
A
parents
n=35
NA
parents
n=22
All
n=56
A
parents
n=33
NA
parents
n=23
All
n=54
A
parents
n=32
NA
parents
n=22
All
n=38
A
parents
n=23
NA
parents
n=15
B. adolescentis ( % ) 4 0 3 1 5 5 3 0 3 1 2 72 5 2 13 04 1 3 84 55 8 6 15 3
B. breve ( % ) 2 8 2 9 2 7 2 8 2 6 3 23 0 3 32 63 3 3 82 76 1 7 04 7
B. bifidum ( % )3 3 2 6 4 5 3 2 2 9 3 63 2 3 03 54 3 5 03 25 8 7 04 0
C. difficile ( % ) 0 0 0 4 3 54 344 355 3 6 1 4 0
S. aureus ( % ) 6 3 6 3 6 4 7 2 7 4 6 87 9 7 97 87 6 7 57 781 30
Allergic parents (A parents), Non-allergic parents (NA parents).
doi:10.1371/journal.pone.0023031.t003
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significant (Fig. 2E). C. difficile was only detected in two infants and
did not differ between the allergic and non-allergic group neither
the first two months nor at 12 months of age (data not shown). At
twelve months of age the frequencies of all species investigated
were similar in both groups (Fig. 2A–E).
Early Lactobacilli colonization decreases the risk for
allergy at five years of age despite allergic heredity
We further sub-grouped the children considering both parental
allergy and IgE-mediated allergic disease at five. Among the
children with allergic parents, 16 had developed IgE-mediated
allergy and 8 remained non-allergic at five years of age. In the
group of children with non-allergic parents, 11 remained non-
allergic at five years, while 4 children were allergic. These 4
children were excluded from following analyses, as they were too
few subjects for a reliable statistical outcome.
When analyzing the infant gut microbiota of children with
allergic parents, we observed that the frequency of colonization at
two weeks differed between allergic and non-allergic children with
allergic parents (Fig. 3A). In consequence, among children with
allergic parents, the children colonized with Lactobacilli at two
weeks of age were less likely to be allergic at age five.
Also, non-allergic children were colonized with Lactobacilli at
more occasions during the first two months of life (Fig. 3B).
A similar colonization pattern in relation to parental allergy and
allergic disease could also be seen for B. bifidum, although non-
statistically significant (data not shown). More than half of the
children were colonized with S. aureus, already at 1 week of age,
regardless of parental allergy or allergy development.
As previously, at twelve months of age the species investigated
were similar in all groups (data not shown).
The maternal gut microbiota is not influenced by allergy
As the early infant microbiota could depend on exposures
during delivery we investigated the maternal fecal microbiota at
the time around delivery. The maternal frequencies are shown in
Table 3. Among all the mothers investigated (n=48), B. adolescentis
was the most commonly species detected, followed by the
Lactobacilli. S. aureus colonization was rare and C. difficile was
not detected in any of the maternal samples analyzed. The
presence and the relative amounts of the analyzed bacteria did not
differ significantly between non-allergic and allergic mothers.
When correlating paired maternal and infant one-week samples
(n=47) we found significant correlations for B. breve (p=0.030)
and B. bifidum (p=0.002) (data not shown), but not for any of the
other investigated bacteria.
Discussion
Early in life the immune system is immature and requires
stimuli from the environment, such as microbial exposures, to
mature properly. The gut microbiota composition has previously
been reported to differ during infancy prior to the development of
allergic disease, implying a role of the gut microbiota in promoting
tolerance to harmless antigens through education of the immune
system.
In this study we show that, colonization is related to both
allergic heredity and IgE-mediated allergic disease at five years of
age in a well-characterized cohort. We clearly demonstrate that
the proportion of infants colonized with Lactobacilli early in life, is
significantly higher in infants with non-allergic parents than infants
with allergic parents (Fig. 1A). Further, infants with non-allergic
parents are colonized with Lactobacilli more often (Fig. 1B) and
have larger relative amounts of both Lactobacilli and B. bifidum in
their fecal samples than infants with allergic parents. To our
knowledge, this is the first time that colonization during infancy is
shown to be associated with parental allergic status. In previous
studies [4,18,19] most of the parents, especially the mothers, were
allergic and the authors could not compare with children having
non-allergic parents.
In this context, it is interesting to note that levels of endotoxin in
house dust are reported to be lower in families with allergic parents
[25]. This can potentially reflect the number of bacteria that the
infant encounters as it has previously been shown that higher
Figure 2. Early life gut microbiota composition associates with allergic disease at age five. The y-axis shows the percentage, colonized
with (A) Lactobacilli, (B) B. bifidum,( C) B. breve,( D) B. adolescentis and (E) S. aureus. Solid line; non-allergic children n=16–19. Dashed line; allergic
children n=18–20 (1 v–2 m), n=9 (12 m).
doi:10.1371/journal.pone.0023031.g002
Early-Life Microbiota and Allergy
PLoS ONE | www.plosone.org 5 August 2011 | Volume 6 | Issue 8 | e23031endotoxin levels are associated with an increased number of
bifidobacteria species in infant feces [4].
In addition, we are able to confirm previously published results
from our group [4] that among five-year old children, non-
allergics are significantly more often colonized with Lactobacilli,
compared to children developing IgE-mediated allergic disease
(Fig. 2A). Recently, Penders et al also reported similar results in a
large cohort, including several hundred children, evaluated at a
Figure 3. Colonization with Lactobacilli the first year of life, sub grouped according to both parental allergy and allergy at five
years of age. Proportion of infants, in percentage, the different time points investigated in (A). Percentage infants colonized 0 or 1–4 occasions the
first two months of life in (B).
doi:10.1371/journal.pone.0023031.g003
Table 3. Frequencies of species investigated among allergic and non-allergic mothers.
All %
(n=48) Allergic mothers % (n=30) Non-Allergic mothers % (n=18)
Lactobacilli 71 67 78
B. adolescentis 79 73 89
B. breve 10 17 0
B. bifidum 44 37 56
C. difficile 00 0
S. aureus 13 13 11
doi:10.1371/journal.pone.0023031.t002
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having B. bifidum is higher among the non-allergic children
throughout the first months of life (Fig. 2B) and in line with
Ouwehand et al [27]. They report that B. bifidum was less often
detected in already allergic children compared to their age-
matched non-allergic controls. B. bifidum has previously been
correlated with IgA in saliva at 12 months of age [13] which
potentially could protect sensitized infants from developing allergic
symptoms as secretory IgA is suggested to block the allergen and
IgE interaction [28].
In our study S. aureus was more commonly detected among
children developing allergy, although not statistically significant
(Fig. 2E) thus the relation between S. aureus and allergy
development remains unclear. However our data regarding S.
aureus as a frequent colonizer during infancy is in line with
previously published results by Adlerberth et al [29].
C. difficile was only detected in two infants the first two months of
life, whereas approximately half of the children harbored C. difficile
at twelve months of age and no association with allergy
development was observed. All infants were vaginally delivered,
exclusively breast-fed and none received antibiotics during the first
three months of life, which may explain the low prevalence of C.
difficile as it is more prevalent in caesarean delivered and formula
fed infants [19].
Generally the kinetics of colonization postnatally seems to differ
in the non-allergic children compared to the allergic children
where the children developing allergy seems to have a delayed
colonization in early infancy (Fig. 2). On the contrary, at twelve
months of age the groups of children were similar in the
frequencies of the different species investigated, suggesting that it
is the early microbiota exposure that is of importance for future
development of allergic disease.
Importantly, we were further able to demonstrate that among
children with allergic parents, infants colonized with Lactobacilli
were less likely to be allergic at the age of five (Fig. 3A). This might
suggest that colonization with Lactobacilli protects against
development of allergic disease despite parental allergy. Support-
ing this interpretation are data from studies where probiotic
supplementation early in life, with different species of Lactobacilli,
reduced clinical outcomes such as eczema and/or IgE sensitization
[30–31]. Recently, administration of L. rhamnous protected against
allergen-induced allergic disease in a pig model [32]. Also, a
reduction of specific IgE accompanied by increased specific IgG
following Lactobacilli administration to patients compared to
placebo-treatment has been reported [33]. However there are also
studies reporting no beneficial effects on neither allergic symptoms
nor IgE sensitization following probiotic supplementation [34–36].
When investigating the maternal fecal microbiota we found that
the allergic and non-allergic mothers were similarly colonized with
regards to the bacteria analyzed. A correlation between maternal
and infant B. breve and B. bifidum colonization was observed the first
week of life. Unfortunately, neither breast milk samples nor
vaginal swabs were collected thus we cannot exclude that the
infants are differently exposed. Gro ¨nlund et al has reported lower
counts of bifidobacteria in breast milk from allergic mothers
compared to non-allergic mothers [37].
The number of children investigated here equals most of the
other similar studies, though we should acknowledge the small
sample size when subgrouping, thus future studies with more
subjects are needed to elucidate the actual role of the microbiota in
relation to allergy development. However, results from a recent
study by Penders et al [26] investigating a cohort with more than
600 children supports our findings. Also, many statistical tests were
done, potentially generating false significances. Strengths of this
study are that all infants were born term, vaginally delivered and
breast fed the first three months of life, factors known to influence
the microbiota composition. Further, we have investigated the gut
microbiota at several occasions in the same children. Also, we have
included children with both allergic and non-allergic parents,
enabling us to evaluate the association between parental allergy
and early colonization. Finally, we evaluated early gut flora in
relation to allergy, based both on SPT and/or specific IgE and
allergic symptoms at five years of age. Many other studies have
eczema and wheezing/asthma as an outcome but it is known that
approximately half of the children with those symptoms are not
IgE sensitized. To consider IgE sensitization in combination with
allergic symptoms gives a better classification of IgE mediated
allergic disease.
In this study we clearly demonstrate that parental allergy has an
impact on the infant gut microbiota, and that early Lactobacilli
(L.casei, L. paracasei, L. rhamnosus) colonization seems to decrease the
risk for allergy at five years of age despite allergic heredity. Even
though previous results regarding allergy development and early
probiotic supplementation are contradictory, our findings suggest
that the naturally acquired gut microbiota has an impact on
allergic disease. The exact mechanisms on how the different
species interact with and influence the immune system are unclear
and require further investigation.
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